Top in cardiology: Implant for coronary artery disease; Fasting vs. no fasting

Results from the INFINITY-SWEDEHEART trial showed that Elixir Medical’s drug-eluting coronary implant was noninferior to a drug-eluting stent for target lesion failure at 1 year.

It was also linked to fewer target lesion failure events after 6 months.

“The DynamX coronary bioadaptor system represents a significant clinical advancement in the treatment of coronary artery disease with a unique mechanism of action of restoring hemodynamic modulation and physiology (vessel natural function) 6 months following the percutaneous coronary intervention procedure,” David Erlinge, MD, PhD, head of the cardiology department at Skane University Hospital, Lund, Sweden, who presented the results at the European Society of Cardiology Congress, told Healio.

It was the top story in cardiology last week.

In another top story, researchers found that not fasting before cardiac catheterization procedures with conscious sedation was just as safe as fasting.

Additionally, they observed better patient satisfaction scores in patients who did not fast.

Read these and more top stories in cardiology below:

Coronary implant noninferior to DES at 1 year, tied to event reduction after 6 months

The bioadaptor implant adaptable to vessel physiology was noninferior to a drug-eluting stent for target lesion failure at 1 year, and reduced event rates vs. the DES after 6 months, researchers reported. Read more.

Fasting not necessary for cardiac catheterization procedures with conscious sedation

Not fasting before cardiac catheterization procedures with conscious sedation was noninferior and improved patient satisfaction, researchers reported at the European Society of Cardiology Congress. Read more.

Stopping abelacimab may not be necessary before invasive procedures

Patients with atrial fibrillation needing stroke prevention who received abelacimab had very low rates of bleeding during invasive procedures, according to new data from the AZALEA-TIMI 71 trial. Read more.

Prevalence of atrial fibrillation in U.S. adults much higher than previous estimates

Nearly one in 20 adults in the U.S. are estimated to have atrial fibrillation, many more than previous studies had indicated, according to new data from researchers at University of California, San Francisco. Read more.

TAVR superior to surgery at 1 year for women with severe aortic stenosis

Women with symptomatic severe aortic stenosis had better outcomes at 1 year after transcatheter aortic valve replacement with a balloon-expandable valve compared with women who underwent surgery, according to new data from the RHEIA trial. Read more.